Nagalakshmi Nadiminty Selected Research

Nagalakshmi Nadiminty Research Topics

Disease

34	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 07/2005
21	Neoplasms (Cancer) 03/2022 - 02/2005
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 05/2007
2	Melanoma (Melanoma, Malignant) 05/2007 - 02/2005
1	Infertility (Sterility) 06/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Carcinogenesis 01/2012
1	Bone Resorption 06/2008
1	Inflammation (Inflammations) 07/2007
1	Ovarian Neoplasms (Ovarian Cancer) 05/2007
1	Lymphoma (Lymphomas) 05/2007
1	Hyperplasia 05/2006
1	Neoplasm Metastasis (Metastasis) 03/2006
1	Osteosarcoma (Osteogenic Sarcoma) 03/2006
1	Lung Neoplasms (Lung Cancer) 04/2005
1	Breast Neoplasms (Breast Cancer) 04/2005

Drug/Important Bio-Agent (IBA)

20	Androgen Receptors (Androgen Receptor)IBA 12/2017 - 07/2005
16	AndrogensIBA 04/2016 - 07/2005
7	enzalutamideIBA 12/2017 - 08/2013
5	Interleukin-6 (Interleukin 6)IBA 08/2014 - 05/2007
4	Androgen Antagonists (Antiandrogens)IBA 01/2017 - 07/2006
4	NF-kappa B p52 SubunitIBA 04/2010 - 07/2007
4	SeleniumIBA 11/2008 - 04/2005
3	Docetaxel (Taxotere)FDA Link 06/2014 - 03/2013
3	SurvivinIBA 01/2012 - 07/2007
3	Prostate-Specific Antigen (Semenogelase)IBA 07/2006 - 03/2006
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2022 - 01/2021
2	Niclosamide FDA Link 01/2017 - 06/2014
2	Small Interfering RNA (siRNA)IBA 04/2015 - 03/2013
2	MicroRNAs (MicroRNA)IBA 01/2012 - 01/2012
2	AlkaloidsIBA 01/2012 - 03/2010
2	sanguinarineIBA 01/2012 - 03/2010
2	andrographolideIBA 02/2011 - 08/2010
2	Interleukin-4 (Interleukin 4)IBA 02/2009 - 07/2005
2	NF-kappa B (NF-kB)IBA 05/2006 - 07/2005
2	LigandsIBA 03/2006 - 04/2005
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Cisplatin (Platino)FDA LinkGeneric 03/2022
1	PlatinumIBA 03/2022
1	olaparibIBA 01/2021
1	veliparibIBA 01/2021
1	rucaparibIBA 01/2021
1	niraparibIBA 01/2021
1	talazoparibIBA 01/2021
1	RNA Splicing FactorsIBA 12/2017
1	QuercetinIBA 12/2017
1	bicalutamide (Casodex)FDA LinkGeneric 01/2017
1	abirateroneIBA 04/2015
1	SteroidsIBA 04/2015
1	Dehydroepiandrosterone (DHEA)IBA 04/2015
1	Progesterone FDA LinkGeneric 04/2015
1	Indomethacin (Indometacin)FDA LinkGeneric 04/2015
1	CholesterolIBA 04/2015
1	Glucose (Dextrose)FDA LinkGeneric 06/2014
1	Guanine Nucleotide Dissociation Inhibitors (GDIs)IBA 11/2013
1	ApigeninIBA 09/2013
1	flavoneIBA 09/2013
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2012
1	DiterpenesIBA 08/2010
1	LactonesIBA 08/2010
1	Antineoplastic Agents (Antineoplastics)IBA 03/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2010
1	EnzymesIBA 08/2009
1	Testosterone (Sustanon)FDA Link 08/2009
1	MicronutrientsIBA 11/2008
1	RANK LigandIBA 06/2008
1	Charcoal (Charbon)IBA 09/2007
1	Proteins (Proteins, Gene)FDA Link 07/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007
1	Oncogene Proteins (Oncogene Protein)IBA 07/2007
1	CytokinesIBA 07/2007
1	Cyclin D1IBA 07/2007
1	Growth InhibitorsIBA 05/2007
1	selenomethylselenocysteine (methylselenocysteine)IBA 07/2006
1	methylselenic acidIBA 07/2006
1	matrigelIBA 07/2006
1	Complementary DNA (cDNA)IBA 03/2006
1	OsteoprotegerinIBA 03/2006
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 03/2006
1	Serine Proteases (Serine Protease)IBA 03/2006
1	Messenger RNA (mRNA)IBA 04/2005
1	Estrogen Receptor betaIBA 04/2005
1	Estrogen ReceptorsIBA 04/2005
1	CarcinogensIBA 04/2005
1	Estrogen Receptor alphaIBA 04/2005
1	Estrogens (Estrogen)FDA Link 04/2005
1	isoeugenolIBA 02/2005
1	E2F Transcription FactorsIBA 02/2005
1	EugenolIBA 02/2005
1	A 19IBA 02/2005

Therapy/Procedure

19	Castration 12/2017 - 02/2009
13	Therapeutics 01/2017 - 02/2005
2	Drug Therapy (Chemotherapy) 03/2022 - 03/2010
1	Chemoprevention 11/2008
1	Intraperitoneal Injections 07/2006